Publications

09 Sep 2008
First Look

First Look: September 9, 2008

patient's health outcomes since 1995. The protagonist of the case, Dr. James Goldfarb, faces a number of challenges. As the medical director of a nationally-renowned fertility program at the Cleveland Clinic, he must run an efficient and... View Details

Keywords: Sean Silverthorne

26 Jul 2016
First Look

July 26, 2016

organizing care around medical conditions, not simply around hospitals and doctors. We need to do more team-based medicine and to better integrate specialty care with primary care. We need to be doing a better job measuring health... View Details

Keywords: Sean Silverthorne

January 2014 (Revised December 2014)
Case

GenapSys: Business Models for the Genome

By: Richard G. Hamermesh, Joseph B. Fuller and Matthew Preble

GenapSys, a California-based startup, was soon to release a new DNA sequencer that the company's founder, Hesaam Esfandyarpour, believed was truly revolutionary. The sequencer would be substantially less expensive—potentially costing just a few thousand dollars—and... View Details

Keywords: DNA Sequencing; Life Sciences; Business Model; Innovation ＆ Entrepreneurship; Health Care and Treatment; Genetics; Business Strategy; Medical Devices and Supplies Industry; Medical Devices and Supplies Industry; Medical Devices and Supplies Industry; Medical Devices and Supplies Industry; Medical Devices and Supplies Industry; United States

May 1999 (Revised September 2003)
Case

Advanced Inhalation Research, Inc.

This case presents a look at the early start-up phase and development of Advanced Inhalation Research (AIR), a company engaged in the development of a new drug-delivery technology. Focuses on the risks, the steps taken to manage it, and the manner in which the company... View Details

Keywords: Technological Innovation; Risk Management; Valuation; Financing and Loans; Health Care and Treatment; Acquisition; Business Startups; Medical Devices and Supplies Industry

14 Feb 2023
HBS Case

Is Sweden Still 'Sweden'? A Liberal Utopia Grapples with an Identity Crisis

country is shifting away from the liberal Social Democratic Party that has been the benchmark of its system. Fewer young Swedes are joining unions, and American-style private schools and medical care have taken root. “Americans, myself... View Details

Keywords: by Lane Lambert

Article

Eliminating Unintended Bias in Personalized Policies Using Bias-Eliminating Adapted Trees (BEAT)

By: Eva Ascarza and Ayelet Israeli

An inherent risk of algorithmic personalization is disproportionate targeting of individuals from certain groups (or demographic characteristics such as gender or race), even when the decision maker does not intend to discriminate based on those “protected”... View Details

Keywords: Algorithm Bias; Personalization; Targeting; Generalized Random Forests (GRF); Discrimination; Customization and Personalization; Decision Making; Fairness; Mathematical Methods

Read Now

21 Apr 2009
First Look

First Look: April 21, 2009

lifetime value (CLV) has emerged as an important metric to manage and grow customers. Marketing scholars have written many books and articles on this topic. However, most of this research has focused on tactical marketing decisions. While... View Details

Keywords: Martha Lagace

19 May 2015
First Look

First Look: May 19

that allowed patients to conduct online medical consultations with physicians, is considering pursuing a direct-to-consumer (DTC) strategy. Founded in 2006, American Well had, to date, primarily sold its solution to health plans, which... View Details

Keywords: Sean Silverthorne

23 Sep 2019
Blog Post

Distressed Employees? Try Resilience Training

Every year depression affects one in every five employees and costs American businesses $210 billion in medical bills and lost productivity. In fact, for every worker with a depressive disorder, a company loses an average of 32 productive... View Details

Keywords: All Industries

12 Jan 2016
First Look

January 12, 2016

November–December 2015 Operations Research Active Postmarketing Drug Surveillance for Multiple Adverse Events By: Goh, Joel, Margrét V. Bjarnadóttir, Mohsen Bayati, and Stefanos A. Zenios Abstract—Postmarketing drug surveillance is the... View Details

Keywords: Carmen Nobel

21 Jul 2015
First Look

First Look: July 21, 2015

Across three studies, we show that gift givers mis-predict appreciation for socially responsible gifts and that their mis-predictions depend on the nature of their relationship to the recipient. Drawing on research on affective... View Details

Keywords: Sean Silverthorne

November 2023 (Revised April 2024)
Case

BiomX: Bringing Phage Back to the Stage

By: Paul A. Gompers, Elie Ofek, Orna Dan and Emilie Billaud

In the spring of 2023, and following the favorable results of a trial involving its phage cocktail for treating lung infections among cystic fibrosis (CF) patients, the leadership of BiomX had several critical issues to wrestle with. First, given its precarious... View Details

Keywords: Working Capital; Financing and Loans; Health Testing and Trials; Product Development; Research and Development; Science-Based Business; Commercialization; Biotechnology Industry; Pharmaceutical Industry